

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sulfation (GO:0051923) | 6.20741466 |
| 2 | behavioral response to nicotine (GO:0035095) | 5.44826284 |
| 3 | drug transmembrane transport (GO:0006855) | 5.40194766 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.24783841 |
| 5 | lysine catabolic process (GO:0006554) | 5.09491082 |
| 6 | lysine metabolic process (GO:0006553) | 5.09491082 |
| 7 | excretion (GO:0007588) | 4.78979946 |
| 8 | organic cation transport (GO:0015695) | 4.74467542 |
| 9 | phosphate ion transport (GO:0006817) | 4.73849702 |
| 10 | response to mercury ion (GO:0046689) | 4.72632096 |
| 11 | cellular response to ATP (GO:0071318) | 4.72355955 |
| 12 | urate metabolic process (GO:0046415) | 4.67340797 |
| 13 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.56893518 |
| 14 | tryptophan catabolic process (GO:0006569) | 4.52464860 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.52464860 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.52464860 |
| 17 | indolalkylamine metabolic process (GO:0006586) | 4.48969444 |
| 18 | negative regulation of systemic arterial blood pressure (GO:0003085) | 4.45752920 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.43663390 |
| 20 | metanephric nephron tubule development (GO:0072234) | 4.40292558 |
| 21 | metanephric tubule development (GO:0072170) | 4.40292558 |
| 22 | tryptophan metabolic process (GO:0006568) | 4.30530737 |
| 23 | drug transport (GO:0015893) | 4.23058742 |
| 24 | renal absorption (GO:0070293) | 4.19818594 |
| 25 | DNA deamination (GO:0045006) | 4.14233324 |
| 26 | polyol transport (GO:0015791) | 4.07607620 |
| 27 | metanephric nephron epithelium development (GO:0072243) | 4.02053848 |
| 28 | gamma-aminobutyric acid transport (GO:0015812) | 4.00814756 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 3.99782646 |
| 30 | quaternary ammonium group transport (GO:0015697) | 3.97785100 |
| 31 | cell proliferation in forebrain (GO:0021846) | 3.86827665 |
| 32 | response to parathyroid hormone (GO:0071107) | 3.86804780 |
| 33 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.85829867 |
| 34 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.83540538 |
| 35 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.83540538 |
| 36 | regulation of glomerulus development (GO:0090192) | 3.79850602 |
| 37 | flavonoid metabolic process (GO:0009812) | 3.78059613 |
| 38 | tricarboxylic acid cycle (GO:0006099) | 3.72763317 |
| 39 | positive regulation of fatty acid oxidation (GO:0046321) | 3.72340561 |
| 40 | tricarboxylic acid metabolic process (GO:0072350) | 3.70406241 |
| 41 | NADH metabolic process (GO:0006734) | 3.65910801 |
| 42 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.63885990 |
| 43 | metanephric epithelium development (GO:0072207) | 3.63070639 |
| 44 | negative regulation of mast cell activation (GO:0033004) | 3.62210417 |
| 45 | cellular potassium ion homeostasis (GO:0030007) | 3.59986910 |
| 46 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.58521425 |
| 47 | regulation of hippo signaling (GO:0035330) | 3.54729890 |
| 48 | indole-containing compound metabolic process (GO:0042430) | 3.53439142 |
| 49 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.49641896 |
| 50 | serotonin metabolic process (GO:0042428) | 3.49531088 |
| 51 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.49225217 |
| 52 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.48027298 |
| 53 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.48027298 |
| 54 | amine catabolic process (GO:0009310) | 3.45481845 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 3.45481845 |
| 56 | phosphate ion transmembrane transport (GO:0035435) | 3.45418990 |
| 57 | negative regulation of appetite (GO:0032099) | 3.44816625 |
| 58 | negative regulation of response to food (GO:0032096) | 3.44816625 |
| 59 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.42897119 |
| 60 | succinate metabolic process (GO:0006105) | 3.38142405 |
| 61 | amino-acid betaine transport (GO:0015838) | 3.36883707 |
| 62 | carnitine transport (GO:0015879) | 3.36883707 |
| 63 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.34910310 |
| 64 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.34407654 |
| 65 | nephron tubule morphogenesis (GO:0072078) | 3.33586096 |
| 66 | nephron epithelium morphogenesis (GO:0072088) | 3.33586096 |
| 67 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.32819780 |
| 68 | short-chain fatty acid metabolic process (GO:0046459) | 3.32232217 |
| 69 | sphingosine metabolic process (GO:0006670) | 3.31813723 |
| 70 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.31078316 |
| 71 | cytidine metabolic process (GO:0046087) | 3.30666275 |
| 72 | cytidine catabolic process (GO:0006216) | 3.30666275 |
| 73 | cytidine deamination (GO:0009972) | 3.30666275 |
| 74 | sphingoid metabolic process (GO:0046519) | 3.29131595 |
| 75 | negative regulation of platelet activation (GO:0010544) | 3.26667822 |
| 76 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.25109029 |
| 77 | glutathione biosynthetic process (GO:0006750) | 3.21657331 |
| 78 | membrane repolarization during action potential (GO:0086011) | 3.21265984 |
| 79 | primary amino compound metabolic process (GO:1901160) | 3.19687461 |
| 80 | sodium ion export (GO:0071436) | 3.17403709 |
| 81 | diol metabolic process (GO:0034311) | 3.16545264 |
| 82 | aromatic amino acid family catabolic process (GO:0009074) | 3.11929485 |
| 83 | nephron tubule development (GO:0072080) | 3.08810563 |
| 84 | DNA methylation involved in gamete generation (GO:0043046) | 3.06440617 |
| 85 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.04750902 |
| 86 | synaptic vesicle exocytosis (GO:0016079) | 3.03896056 |
| 87 | ATP synthesis coupled proton transport (GO:0015986) | 3.02313910 |
| 88 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.02313910 |
| 89 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.01225855 |
| 90 | regulation of collateral sprouting (GO:0048670) | 3.00632609 |
| 91 | protein polyglutamylation (GO:0018095) | 3.00132916 |
| 92 | peristalsis (GO:0030432) | 3.00033471 |
| 93 | cellular ketone body metabolic process (GO:0046950) | 2.97298915 |
| 94 | cell communication by electrical coupling (GO:0010644) | 2.96444852 |
| 95 | respiratory electron transport chain (GO:0022904) | 2.96041803 |
| 96 | 2-oxoglutarate metabolic process (GO:0006103) | 2.93747547 |
| 97 | lactate metabolic process (GO:0006089) | 2.93364086 |
| 98 | electron transport chain (GO:0022900) | 2.92911264 |
| 99 | dopamine transport (GO:0015872) | 2.92173357 |
| 100 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.92163584 |
| 101 | regulation of gene silencing by miRNA (GO:0060964) | 2.92163584 |
| 102 | regulation of gene silencing by RNA (GO:0060966) | 2.92163584 |
| 103 | regulation of sequestering of triglyceride (GO:0010889) | 2.91733269 |
| 104 | regulation of DNA endoreduplication (GO:0032875) | 2.91009653 |
| 105 | piRNA metabolic process (GO:0034587) | 2.89670811 |
| 106 | glycoside metabolic process (GO:0016137) | 2.89307104 |
| 107 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.86800413 |
| 108 | renal tubule morphogenesis (GO:0061333) | 2.86598843 |
| 109 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.86254044 |
| 110 | L-fucose catabolic process (GO:0042355) | 2.86133709 |
| 111 | fucose catabolic process (GO:0019317) | 2.86133709 |
| 112 | L-fucose metabolic process (GO:0042354) | 2.86133709 |
| 113 | aromatic amino acid family metabolic process (GO:0009072) | 2.86017541 |
| 114 | regulation of neurotransmitter uptake (GO:0051580) | 2.85736955 |
| 115 | sodium ion transport (GO:0006814) | 2.84381388 |
| 116 | dorsal/ventral axis specification (GO:0009950) | 2.83063006 |
| 117 | detection of calcium ion (GO:0005513) | 2.82924163 |
| 118 | detection of light stimulus involved in visual perception (GO:0050908) | 2.82878670 |
| 119 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.82878670 |
| 120 | renal tubule development (GO:0061326) | 2.82249445 |
| 121 | protein neddylation (GO:0045116) | 2.80895716 |
| 122 | actin filament depolymerization (GO:0030042) | 2.79543203 |
| 123 | tachykinin receptor signaling pathway (GO:0007217) | 2.79427922 |
| 124 | transferrin transport (GO:0033572) | 2.79213787 |
| 125 | reflex (GO:0060004) | 2.78508634 |
| 126 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.78464972 |
| 127 | adaptation of signaling pathway (GO:0023058) | 2.76347382 |
| 128 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.76084675 |
| 129 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.76057307 |
| 130 | collecting duct development (GO:0072044) | 2.75700437 |
| 131 | water transport (GO:0006833) | 2.74715744 |
| 132 | sulfate transmembrane transport (GO:1902358) | 2.72795398 |
| 133 | neuronal action potential (GO:0019228) | 2.72409483 |
| 134 | polyol catabolic process (GO:0046174) | 2.71549523 |
| 135 | glutamate secretion (GO:0014047) | 2.70845072 |
| 136 | glyoxylate metabolic process (GO:0046487) | 2.70526240 |
| 137 | otic vesicle formation (GO:0030916) | 2.70179330 |
| 138 | branched-chain amino acid metabolic process (GO:0009081) | 2.70047984 |
| 139 | peptide biosynthetic process (GO:0043043) | 2.68536371 |
| 140 | phasic smooth muscle contraction (GO:0014821) | 2.68032306 |
| 141 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.67857412 |
| 142 | oxaloacetate metabolic process (GO:0006107) | 2.67856688 |
| 143 | trivalent inorganic cation transport (GO:0072512) | 2.67855899 |
| 144 | ferric iron transport (GO:0015682) | 2.67855899 |
| 145 | positive regulation of digestive system process (GO:0060456) | 2.67335804 |
| 146 | bicarbonate transport (GO:0015701) | 2.67217336 |
| 147 | benzene-containing compound metabolic process (GO:0042537) | 2.66959728 |
| 148 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.66574058 |
| 149 | pharyngeal system development (GO:0060037) | 2.66376546 |
| 150 | neurotransmitter secretion (GO:0007269) | 2.65882102 |
| 151 | rhodopsin mediated signaling pathway (GO:0016056) | 2.64665302 |
| 152 | cellular anion homeostasis (GO:0030002) | 2.64371529 |
| 153 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.64283848 |
| 154 | somite development (GO:0061053) | 2.64199876 |
| 155 | drug catabolic process (GO:0042737) | 2.64162791 |
| 156 | photoreceptor cell development (GO:0042461) | 2.62152316 |
| 157 | relaxation of cardiac muscle (GO:0055119) | 2.62089022 |
| 158 | vitamin D metabolic process (GO:0042359) | 2.61822720 |
| 159 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.61122324 |
| 160 | GPI anchor metabolic process (GO:0006505) | 2.61062089 |
| 161 | inositol metabolic process (GO:0006020) | 2.59540750 |
| 162 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.58410135 |
| 163 | neurotransmitter transport (GO:0006836) | 2.58384707 |
| 164 | potassium ion import (GO:0010107) | 2.58080568 |
| 165 | hydrogen ion transmembrane transport (GO:1902600) | 2.57668495 |
| 166 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.56324760 |
| 167 | membrane repolarization (GO:0086009) | 2.55779655 |
| 168 | transmission of nerve impulse (GO:0019226) | 2.55467337 |
| 169 | dopamine biosynthetic process (GO:0042416) | 2.54988385 |
| 170 | negative regulation of multicellular organism growth (GO:0040015) | 2.53558051 |
| 171 | NAD biosynthetic process (GO:0009435) | 2.53484236 |
| 172 | negative regulation by host of viral transcription (GO:0043922) | 2.53234163 |
| 173 | neuronal action potential propagation (GO:0019227) | 2.52982447 |
| 174 | cysteine metabolic process (GO:0006534) | 2.52505139 |
| 175 | ketone body metabolic process (GO:1902224) | 2.52256740 |
| 176 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.51852084 |
| 177 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.51852084 |
| 178 | NADH dehydrogenase complex assembly (GO:0010257) | 2.51852084 |
| 179 | negative regulation of telomere maintenance (GO:0032205) | 2.51513771 |
| 180 | locomotory exploration behavior (GO:0035641) | 2.51312532 |
| 181 | positive regulation of meiosis (GO:0045836) | 2.51024761 |
| 182 | regulation of synaptic vesicle transport (GO:1902803) | 2.49411826 |
| 183 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.48784051 |
| 184 | positive regulation of metanephros development (GO:0072216) | 2.48013019 |
| 185 | eye photoreceptor cell development (GO:0042462) | 2.47436249 |
| 186 | cornea development in camera-type eye (GO:0061303) | 2.46360552 |
| 187 | vocalization behavior (GO:0071625) | 2.46244053 |
| 188 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.44739814 |
| 189 | L-phenylalanine catabolic process (GO:0006559) | 2.44739814 |
| 190 | nephron epithelium development (GO:0072009) | 2.44504230 |
| 191 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.44463138 |
| 192 | negative regulation of hormone metabolic process (GO:0032351) | 2.44463138 |
| 193 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.44411613 |
| 194 | regulation of cAMP-mediated signaling (GO:0043949) | 2.43982343 |
| 195 | response to pheromone (GO:0019236) | 2.43158103 |
| 196 | hyperosmotic salinity response (GO:0042538) | 2.39829656 |
| 197 | fluid transport (GO:0042044) | 2.39011998 |
| 198 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.38665937 |
| 199 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.38368888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.27559835 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.33196840 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.61055001 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.48549958 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.40785099 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.40580288 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.30944722 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.25649263 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.16449487 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.12618025 |
| 11 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.12401488 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.08729551 |
| 13 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.08283161 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.07158130 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.04070634 |
| 16 | FUS_26573619_Chip-Seq_HEK293_Human | 2.02265622 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.01227567 |
| 18 | EWS_26573619_Chip-Seq_HEK293_Human | 1.96637858 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.90666566 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.90666566 |
| 21 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.88284501 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.87222303 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.86812730 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.86151291 |
| 25 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.77970138 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.77744852 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.75152555 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.73315840 |
| 29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.72643146 |
| 30 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.69941112 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67890807 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66185841 |
| 33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64327683 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.64036540 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.64019985 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.64006407 |
| 37 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.62704176 |
| 38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.58806415 |
| 39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.55066405 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.53734609 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50980324 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49562416 |
| 43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.49245358 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48996704 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48356158 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43823330 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42752339 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42729631 |
| 49 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.39495468 |
| 50 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.38747060 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35090247 |
| 52 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34392143 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.33944658 |
| 54 | TP53_16413492_ChIP-PET_HCT116_Human | 1.33202327 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31026723 |
| 56 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.31009605 |
| 57 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.31009605 |
| 58 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29832283 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.29180364 |
| 60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28105766 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26923739 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26214096 |
| 63 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25497551 |
| 64 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24499335 |
| 65 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.24321324 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24285614 |
| 67 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.24260705 |
| 68 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22588933 |
| 69 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.20329579 |
| 70 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.19907491 |
| 71 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19503741 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19300173 |
| 73 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.18879408 |
| 74 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18879408 |
| 75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17871830 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17729208 |
| 77 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16635009 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15743154 |
| 79 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.14322914 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14072942 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13947667 |
| 82 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13375729 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.13287454 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.13287454 |
| 85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12697781 |
| 86 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12665705 |
| 87 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.10986591 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10823294 |
| 89 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.09203985 |
| 90 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08610465 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08034554 |
| 92 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07639010 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07446755 |
| 94 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06479371 |
| 95 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.05877159 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05862199 |
| 97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05520052 |
| 98 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05010778 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04617336 |
| 100 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03672020 |
| 101 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03433730 |
| 102 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02764239 |
| 103 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02677373 |
| 104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02358616 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02148964 |
| 106 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01718048 |
| 107 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01550739 |
| 108 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.01292084 |
| 109 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01267073 |
| 110 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00355284 |
| 111 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.99898442 |
| 112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99833736 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99547269 |
| 114 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99342148 |
| 115 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98553209 |
| 116 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98392214 |
| 117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96288486 |
| 118 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95484660 |
| 119 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95484660 |
| 120 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94804202 |
| 121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94759587 |
| 122 | * AR_19668381_ChIP-Seq_PC3_Human | 0.94707965 |
| 123 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94583164 |
| 124 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.92633362 |
| 125 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91240179 |
| 126 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90314877 |
| 127 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89297531 |
| 128 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89240040 |
| 129 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88602872 |
| 130 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88201100 |
| 131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87915703 |
| 132 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87113217 |
| 133 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87036160 |
| 134 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86777445 |
| 135 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86684912 |
| 136 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86506650 |
| 137 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86211733 |
| 138 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.85961543 |
| 139 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85152091 |
| 140 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84412912 |
| 141 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.84355283 |
| 142 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.84333548 |
| 143 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.84220461 |
| 144 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84027110 |
| 145 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82990651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 7.14009817 |
| 2 | MP0003195_calcinosis | 4.24808835 |
| 3 | MP0001765_abnormal_ion_homeostasis | 3.37883692 |
| 4 | MP0005360_urolithiasis | 3.24521200 |
| 5 | MP0005171_absent_coat_pigmentation | 3.16847152 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.95383676 |
| 7 | MP0001756_abnormal_urination | 2.92943940 |
| 8 | MP0006292_abnormal_olfactory_placode | 2.84659865 |
| 9 | MP0005332_abnormal_amino_acid | 2.68919923 |
| 10 | MP0002653_abnormal_ependyma_morphology | 2.68904720 |
| 11 | MP0003136_yellow_coat_color | 2.65119565 |
| 12 | MP0008872_abnormal_physiological_respon | 2.63884760 |
| 13 | MP0004859_abnormal_synaptic_plasticity | 2.55397335 |
| 14 | MP0009643_abnormal_urine_homeostasis | 2.48235865 |
| 15 | MP0001485_abnormal_pinna_reflex | 2.40604372 |
| 16 | MP0005636_abnormal_mineral_homeostasis | 2.35803543 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.35735733 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.31544044 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.24225470 |
| 20 | MP0003880_abnormal_central_pattern | 2.21666499 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 2.14931333 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 2.08329349 |
| 23 | MP0002102_abnormal_ear_morphology | 2.03608540 |
| 24 | MP0008961_abnormal_basal_metabolism | 2.02633080 |
| 25 | MP0004134_abnormal_chest_morphology | 2.01990712 |
| 26 | MP0010386_abnormal_urinary_bladder | 2.01673138 |
| 27 | MP0004270_analgesia | 2.01277660 |
| 28 | MP0002160_abnormal_reproductive_system | 1.99955493 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.98160203 |
| 30 | MP0008877_abnormal_DNA_methylation | 1.93601997 |
| 31 | MP0003283_abnormal_digestive_organ | 1.89724786 |
| 32 | MP0000013_abnormal_adipose_tissue | 1.87170517 |
| 33 | MP0009046_muscle_twitch | 1.82766483 |
| 34 | MP0000631_abnormal_neuroendocrine_gland | 1.79802896 |
| 35 | MP0002064_seizures | 1.78333443 |
| 36 | MP0009745_abnormal_behavioral_response | 1.77623390 |
| 37 | MP0004142_abnormal_muscle_tone | 1.74314792 |
| 38 | MP0004885_abnormal_endolymph | 1.73838358 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.66266399 |
| 40 | MP0002136_abnormal_kidney_physiology | 1.65135852 |
| 41 | MP0002938_white_spotting | 1.64169698 |
| 42 | MP0000372_irregular_coat_pigmentation | 1.61413749 |
| 43 | MP0002909_abnormal_adrenal_gland | 1.59574509 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.59154425 |
| 45 | MP0002063_abnormal_learning/memory/cond | 1.58050236 |
| 46 | MP0000538_abnormal_urinary_bladder | 1.55343852 |
| 47 | MP0005389_reproductive_system_phenotype | 1.53556723 |
| 48 | MP0002734_abnormal_mechanical_nocicepti | 1.53304640 |
| 49 | MP0004130_abnormal_muscle_cell | 1.49751896 |
| 50 | MP0005535_abnormal_body_temperature | 1.49668446 |
| 51 | MP0002736_abnormal_nociception_after | 1.48270963 |
| 52 | MP0005670_abnormal_white_adipose | 1.47266386 |
| 53 | MP0002139_abnormal_hepatobiliary_system | 1.45576220 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.45163480 |
| 55 | MP0003890_abnormal_embryonic-extraembry | 1.44124535 |
| 56 | MP0003879_abnormal_hair_cell | 1.42768288 |
| 57 | MP0002572_abnormal_emotion/affect_behav | 1.41553843 |
| 58 | MP0004133_heterotaxia | 1.41352088 |
| 59 | MP0002272_abnormal_nervous_system | 1.40017765 |
| 60 | MP0000049_abnormal_middle_ear | 1.39004251 |
| 61 | MP0004215_abnormal_myocardial_fiber | 1.38135685 |
| 62 | MP0001440_abnormal_grooming_behavior | 1.36342319 |
| 63 | MP0003122_maternal_imprinting | 1.35907477 |
| 64 | MP0002735_abnormal_chemical_nociception | 1.35503141 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.33786957 |
| 66 | MP0003329_amyloid_beta_deposits | 1.33402051 |
| 67 | MP0002067_abnormal_sensory_capabilities | 1.33013915 |
| 68 | MP0003638_abnormal_response/metabolism_ | 1.32272157 |
| 69 | MP0000230_abnormal_systemic_arterial | 1.29831006 |
| 70 | MP0002163_abnormal_gland_morphology | 1.27699368 |
| 71 | MP0005253_abnormal_eye_physiology | 1.24792157 |
| 72 | MP0001501_abnormal_sleep_pattern | 1.24126893 |
| 73 | MP0003646_muscle_fatigue | 1.23327087 |
| 74 | MP0005410_abnormal_fertilization | 1.20724720 |
| 75 | MP0003045_fibrosis | 1.18324891 |
| 76 | MP0003724_increased_susceptibility_to | 1.17247118 |
| 77 | MP0000751_myopathy | 1.15967510 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 1.15965890 |
| 79 | MP0001986_abnormal_taste_sensitivity | 1.11961496 |
| 80 | MP0003878_abnormal_ear_physiology | 1.11535285 |
| 81 | MP0005377_hearing/vestibular/ear_phenot | 1.11535285 |
| 82 | MP0001486_abnormal_startle_reflex | 1.10489283 |
| 83 | MP0004036_abnormal_muscle_relaxation | 1.10431820 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 1.10273123 |
| 85 | MP0003937_abnormal_limbs/digits/tail_de | 1.08943509 |
| 86 | MP0002928_abnormal_bile_duct | 1.07840008 |
| 87 | MP0005646_abnormal_pituitary_gland | 1.07437835 |
| 88 | MP0002733_abnormal_thermal_nociception | 1.07358907 |
| 89 | MP0009250_abnormal_appendicular_skeleto | 1.05210129 |
| 90 | MP0001944_abnormal_pancreas_morphology | 1.04915902 |
| 91 | MP0001970_abnormal_pain_threshold | 1.04015633 |
| 92 | MP0006276_abnormal_autonomic_nervous | 1.02527728 |
| 93 | MP0003252_abnormal_bile_duct | 1.01440506 |
| 94 | MP0003011_delayed_dark_adaptation | 0.99533477 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 0.99525948 |
| 96 | MP0004484_altered_response_of | 0.96154419 |
| 97 | MP0000613_abnormal_salivary_gland | 0.95825596 |
| 98 | MP0010329_abnormal_lipoprotein_level | 0.95230168 |
| 99 | MP0000678_abnormal_parathyroid_gland | 0.94206197 |
| 100 | MP0002822_catalepsy | 0.93619285 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.93324024 |
| 102 | MP0004924_abnormal_behavior | 0.93324024 |
| 103 | MP0002069_abnormal_eating/drinking_beha | 0.93080958 |
| 104 | MP0002557_abnormal_social/conspecific_i | 0.93038198 |
| 105 | MP0005083_abnormal_biliary_tract | 0.92214066 |
| 106 | MP0004147_increased_porphyrin_level | 0.91670018 |
| 107 | MP0001502_abnormal_circadian_rhythm | 0.91223944 |
| 108 | MP0004084_abnormal_cardiac_muscle | 0.89797756 |
| 109 | MP0003119_abnormal_digestive_system | 0.89503691 |
| 110 | MP0005195_abnormal_posterior_eye | 0.88822994 |
| 111 | MP0005620_abnormal_muscle_contractility | 0.86827788 |
| 112 | MP0000026_abnormal_inner_ear | 0.86094832 |
| 113 | MP0002066_abnormal_motor_capabilities/c | 0.85957927 |
| 114 | MP0002168_other_aberrant_phenotype | 0.85299752 |
| 115 | MP0001963_abnormal_hearing_physiology | 0.84876344 |
| 116 | MP0001664_abnormal_digestion | 0.84744348 |
| 117 | MP0003953_abnormal_hormone_level | 0.84556486 |
| 118 | MP0005379_endocrine/exocrine_gland_phen | 0.83687273 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83202257 |
| 120 | MP0004145_abnormal_muscle_electrophysio | 0.82403063 |
| 121 | MP0000747_muscle_weakness | 0.80698075 |
| 122 | MP0002972_abnormal_cardiac_muscle | 0.80486769 |
| 123 | MP0000383_abnormal_hair_follicle | 0.80417143 |
| 124 | MP0004085_abnormal_heartbeat | 0.80361908 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.79754492 |
| 126 | MP0005085_abnormal_gallbladder_physiolo | 0.79713387 |
| 127 | MP0008789_abnormal_olfactory_epithelium | 0.79087578 |
| 128 | MP0004742_abnormal_vestibular_system | 0.78392527 |
| 129 | MP0003633_abnormal_nervous_system | 0.78035527 |
| 130 | MP0000427_abnormal_hair_cycle | 0.77248623 |
| 131 | MP0002693_abnormal_pancreas_physiology | 0.77166390 |
| 132 | MP0004858_abnormal_nervous_system | 0.77102948 |
| 133 | MP0005084_abnormal_gallbladder_morpholo | 0.75240403 |
| 134 | MP0005423_abnormal_somatic_nervous | 0.74274967 |
| 135 | MP0010234_abnormal_vibrissa_follicle | 0.73870085 |
| 136 | MP0001958_emphysema | 0.73796711 |
| 137 | MP0004233_abnormal_muscle_weight | 0.73784431 |
| 138 | MP0002896_abnormal_bone_mineralization | 0.73672114 |
| 139 | MP0002752_abnormal_somatic_nervous | 0.73602919 |
| 140 | MP0002282_abnormal_trachea_morphology | 0.73548783 |
| 141 | MP0005058_abnormal_lysosome_morphology | 0.72920539 |
| 142 | MP0001919_abnormal_reproductive_system | 0.72800105 |
| 143 | MP0002751_abnormal_autonomic_nervous | 0.72610461 |
| 144 | MP0005645_abnormal_hypothalamus_physiol | 0.71158249 |
| 145 | MP0008569_lethality_at_weaning | 0.70940009 |
| 146 | MP0001984_abnormal_olfaction | 0.70298552 |
| 147 | MP0002638_abnormal_pupillary_reflex | 0.69653001 |
| 148 | MP0006072_abnormal_retinal_apoptosis | 0.68875501 |
| 149 | MP0005075_abnormal_melanosome_morpholog | 0.68459485 |
| 150 | MP0009764_decreased_sensitivity_to | 0.68456075 |
| 151 | MP0003183_abnormal_peptide_metabolism | 0.68334858 |
| 152 | MP0005330_cardiomyopathy | 0.68266418 |
| 153 | MP0002095_abnormal_skin_pigmentation | 0.68062662 |
| 154 | MP0002229_neurodegeneration | 0.67760102 |
| 155 | MP0003787_abnormal_imprinting | 0.67699595 |
| 156 | MP0003959_abnormal_lean_body | 0.67517411 |
| 157 | MP0002277_abnormal_respiratory_mucosa | 0.66921802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 8.07804829 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 7.84820310 |
| 3 | Increased circulating renin level (HP:0000848) | 7.64977348 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 7.18503617 |
| 5 | Abnormality of chloride homeostasis (HP:0011422) | 6.76096657 |
| 6 | Polyuria (HP:0000103) | 6.64556233 |
| 7 | Hypomagnesemia (HP:0002917) | 6.53945237 |
| 8 | Abnormal urine output (HP:0012590) | 6.16890976 |
| 9 | Gout (HP:0001997) | 5.66617051 |
| 10 | Abnormality of renal excretion (HP:0011036) | 5.64881857 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 5.64790466 |
| 12 | Hyperaldosteronism (HP:0000859) | 5.56084810 |
| 13 | Abnormal drinking behavior (HP:0030082) | 5.39658423 |
| 14 | Polydipsia (HP:0001959) | 5.39658423 |
| 15 | Renal salt wasting (HP:0000127) | 5.26874875 |
| 16 | Tetany (HP:0001281) | 5.14331257 |
| 17 | Abnormality of renin-angiotensin system (HP:0000847) | 5.07165926 |
| 18 | Pancreatic cysts (HP:0001737) | 4.79391307 |
| 19 | Alkalosis (HP:0001948) | 4.65888948 |
| 20 | Genetic anticipation (HP:0003743) | 4.48186941 |
| 21 | Pendular nystagmus (HP:0012043) | 4.40366697 |
| 22 | Hypokalemia (HP:0002900) | 4.31902456 |
| 23 | Pancreatic fibrosis (HP:0100732) | 4.20355087 |
| 24 | True hermaphroditism (HP:0010459) | 4.12258061 |
| 25 | Progressive cerebellar ataxia (HP:0002073) | 3.72202035 |
| 26 | Increased purine levels (HP:0004368) | 3.71802574 |
| 27 | Hyperuricemia (HP:0002149) | 3.71802574 |
| 28 | Abnormality of potassium homeostasis (HP:0011042) | 3.64078086 |
| 29 | Ketoacidosis (HP:0001993) | 3.58084113 |
| 30 | Abolished electroretinogram (ERG) (HP:0000550) | 3.47145177 |
| 31 | Proximal tubulopathy (HP:0000114) | 3.34297257 |
| 32 | Abnormality of the renal cortex (HP:0011035) | 3.30133439 |
| 33 | Nephronophthisis (HP:0000090) | 3.23700347 |
| 34 | Keratoconus (HP:0000563) | 3.22597659 |
| 35 | Increased corneal curvature (HP:0100692) | 3.22597659 |
| 36 | Hypercalciuria (HP:0002150) | 3.19644016 |
| 37 | Congenital stationary night blindness (HP:0007642) | 3.07377844 |
| 38 | Abnormality of midbrain morphology (HP:0002418) | 3.00322561 |
| 39 | Molar tooth sign on MRI (HP:0002419) | 3.00322561 |
| 40 | Gaze-evoked nystagmus (HP:0000640) | 2.99228319 |
| 41 | Adrenal overactivity (HP:0002717) | 2.97686116 |
| 42 | Decreased central vision (HP:0007663) | 2.97100383 |
| 43 | Decreased circulating renin level (HP:0003351) | 2.95856543 |
| 44 | Cystic liver disease (HP:0006706) | 2.94358005 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.92180872 |
| 46 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.80273709 |
| 47 | Congenital sensorineural hearing impairment (HP:0008527) | 2.79046106 |
| 48 | Severe visual impairment (HP:0001141) | 2.77242813 |
| 49 | Generalized aminoaciduria (HP:0002909) | 2.76298917 |
| 50 | Abnormality of sodium homeostasis (HP:0010931) | 2.75979212 |
| 51 | 3-Methylglutaconic aciduria (HP:0003535) | 2.70122199 |
| 52 | Ketosis (HP:0001946) | 2.66524342 |
| 53 | Type II lissencephaly (HP:0007260) | 2.65606522 |
| 54 | Hyperglycinuria (HP:0003108) | 2.62233477 |
| 55 | Abnormality of urine glucose concentration (HP:0011016) | 2.58416607 |
| 56 | Glycosuria (HP:0003076) | 2.58416607 |
| 57 | Agitation (HP:0000713) | 2.58092588 |
| 58 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.54939596 |
| 59 | Short 1st metacarpal (HP:0010034) | 2.54939596 |
| 60 | Renal cortical cysts (HP:0000803) | 2.53277615 |
| 61 | Hyponatremia (HP:0002902) | 2.52093249 |
| 62 | Furrowed tongue (HP:0000221) | 2.50936708 |
| 63 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.46021417 |
| 64 | Chorioretinal atrophy (HP:0000533) | 2.45559871 |
| 65 | Methylmalonic acidemia (HP:0002912) | 2.44628451 |
| 66 | Renal tubular acidosis (HP:0001947) | 2.44166381 |
| 67 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.43140530 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.42618607 |
| 69 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.42082882 |
| 70 | Carpal bone hypoplasia (HP:0001498) | 2.39913906 |
| 71 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.37426750 |
| 72 | Hyperphosphaturia (HP:0003109) | 2.31735662 |
| 73 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.29963816 |
| 74 | Absent/shortened dynein arms (HP:0200106) | 2.29963816 |
| 75 | Acanthocytosis (HP:0001927) | 2.28711007 |
| 76 | Acute encephalopathy (HP:0006846) | 2.28514426 |
| 77 | Attenuation of retinal blood vessels (HP:0007843) | 2.26916753 |
| 78 | Abnormality of the nasal septum (HP:0000419) | 2.26820403 |
| 79 | Nephrocalcinosis (HP:0000121) | 2.24800633 |
| 80 | Hemiparesis (HP:0001269) | 2.24585683 |
| 81 | Focal motor seizures (HP:0011153) | 2.21866006 |
| 82 | Short phalanx of the thumb (HP:0009660) | 2.21829295 |
| 83 | Abnormality of the renal collecting system (HP:0004742) | 2.19595673 |
| 84 | Pheochromocytoma (HP:0002666) | 2.19433581 |
| 85 | Hemiplegia (HP:0002301) | 2.19092036 |
| 86 | Asplenia (HP:0001746) | 2.18685052 |
| 87 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.18398776 |
| 88 | Dehydration (HP:0001944) | 2.18201234 |
| 89 | Abnormality of the 1st metacarpal (HP:0010009) | 2.18023382 |
| 90 | Chronic hepatic failure (HP:0100626) | 2.17279138 |
| 91 | Abnormal urine phosphate concentration (HP:0012599) | 2.16666056 |
| 92 | Hypotension (HP:0002615) | 2.16299511 |
| 93 | Hypothermia (HP:0002045) | 2.16057027 |
| 94 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.16041121 |
| 95 | Congenital hepatic fibrosis (HP:0002612) | 2.13513543 |
| 96 | Sclerocornea (HP:0000647) | 2.13358223 |
| 97 | Congenital, generalized hypertrichosis (HP:0004540) | 2.12921265 |
| 98 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.12527351 |
| 99 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.10587607 |
| 100 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.09650961 |
| 101 | Optic nerve hypoplasia (HP:0000609) | 2.08966774 |
| 102 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.07218288 |
| 103 | Porencephaly (HP:0002132) | 2.06604899 |
| 104 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.06232954 |
| 105 | Abnormality of glycine metabolism (HP:0010895) | 2.06232954 |
| 106 | Hyperkalemia (HP:0002153) | 2.05929760 |
| 107 | Male pseudohermaphroditism (HP:0000037) | 2.04342791 |
| 108 | Visual hallucinations (HP:0002367) | 2.04133456 |
| 109 | Abnormal eating behavior (HP:0100738) | 2.03483917 |
| 110 | Acute necrotizing encephalopathy (HP:0006965) | 2.02668365 |
| 111 | Abnormality of binocular vision (HP:0011514) | 2.02154140 |
| 112 | Diplopia (HP:0000651) | 2.02154140 |
| 113 | Medial flaring of the eyebrow (HP:0010747) | 1.99996035 |
| 114 | Tubulointerstitial fibrosis (HP:0005576) | 1.98077557 |
| 115 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.97976019 |
| 116 | Hyperventilation (HP:0002883) | 1.97403084 |
| 117 | Small hand (HP:0200055) | 1.95866545 |
| 118 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.95672686 |
| 119 | Abnormality of DNA repair (HP:0003254) | 1.94697868 |
| 120 | Ectopic kidney (HP:0000086) | 1.92862645 |
| 121 | Abnormal ciliary motility (HP:0012262) | 1.92427082 |
| 122 | Neuroendocrine neoplasm (HP:0100634) | 1.92341242 |
| 123 | Abnormality of chromosome stability (HP:0003220) | 1.92001709 |
| 124 | Amelogenesis imperfecta (HP:0000705) | 1.91471089 |
| 125 | Vomiting (HP:0002013) | 1.90628502 |
| 126 | Anencephaly (HP:0002323) | 1.89406267 |
| 127 | Abnormality of renal resorption (HP:0011038) | 1.89315549 |
| 128 | Inability to walk (HP:0002540) | 1.88611095 |
| 129 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.86717068 |
| 130 | Abnormality of the ileum (HP:0001549) | 1.86116881 |
| 131 | Hypophosphatemia (HP:0002148) | 1.85224947 |
| 132 | Methylmalonic aciduria (HP:0012120) | 1.84978503 |
| 133 | Meckel diverticulum (HP:0002245) | 1.83725945 |
| 134 | Absent thumb (HP:0009777) | 1.82842155 |
| 135 | Short hallux (HP:0010109) | 1.82747398 |
| 136 | Tubular atrophy (HP:0000092) | 1.80410327 |
| 137 | Potter facies (HP:0002009) | 1.79832211 |
| 138 | Facial shape deformation (HP:0011334) | 1.79832211 |
| 139 | IgG deficiency (HP:0004315) | 1.79442397 |
| 140 | Hypoglycemic coma (HP:0001325) | 1.79060635 |
| 141 | Thyroid-stimulating hormone excess (HP:0002925) | 1.79051358 |
| 142 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78653521 |
| 143 | Abnormality of alanine metabolism (HP:0010916) | 1.78653521 |
| 144 | Hyperalaninemia (HP:0003348) | 1.78653521 |
| 145 | Renal tubular dysfunction (HP:0000124) | 1.77876276 |
| 146 | Nephrolithiasis (HP:0000787) | 1.77627901 |
| 147 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.77302991 |
| 148 | Progressive macrocephaly (HP:0004481) | 1.77072096 |
| 149 | Delayed epiphyseal ossification (HP:0002663) | 1.76969830 |
| 150 | Hypoplastic iliac wings (HP:0002866) | 1.76689935 |
| 151 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.76107938 |
| 152 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.76107938 |
| 153 | Dialeptic seizures (HP:0011146) | 1.74703102 |
| 154 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.74332611 |
| 155 | Postaxial foot polydactyly (HP:0001830) | 1.73568714 |
| 156 | Hamartoma of the eye (HP:0010568) | 1.73166742 |
| 157 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73074932 |
| 158 | Progressive inability to walk (HP:0002505) | 1.71958883 |
| 159 | Tinnitus (HP:0000360) | 1.71502482 |
| 160 | Tachypnea (HP:0002789) | 1.71389566 |
| 161 | Cerebellar dysplasia (HP:0007033) | 1.70474474 |
| 162 | Abnormality of nucleobase metabolism (HP:0010932) | 1.70047986 |
| 163 | Metabolic acidosis (HP:0001942) | 1.65923571 |
| 164 | Polyphagia (HP:0002591) | 1.65358694 |
| 165 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.63247226 |
| 166 | Dicarboxylic aciduria (HP:0003215) | 1.63247226 |
| 167 | Atonic seizures (HP:0010819) | 1.62875187 |
| 168 | Abnormality of the renal medulla (HP:0100957) | 1.62415198 |
| 169 | Enlarged kidneys (HP:0000105) | 1.60887024 |
| 170 | Focal seizures (HP:0007359) | 1.60485198 |
| 171 | Lethargy (HP:0001254) | 1.59822190 |
| 172 | Anxiety (HP:0000739) | 1.59390504 |
| 173 | Confusion (HP:0001289) | 1.59008556 |
| 174 | Cerebral edema (HP:0002181) | 1.58761028 |
| 175 | Myokymia (HP:0002411) | 1.58662919 |
| 176 | Generalized muscle weakness (HP:0003324) | 1.58374958 |
| 177 | Irritability (HP:0000737) | 1.58280609 |
| 178 | Goiter (HP:0000853) | 1.57353232 |
| 179 | Chronic bronchitis (HP:0004469) | 1.56651041 |
| 180 | Tubulointerstitial abnormality (HP:0001969) | 1.55819344 |
| 181 | Symptomatic seizures (HP:0011145) | 1.55233604 |
| 182 | Epileptic encephalopathy (HP:0200134) | 1.54584540 |
| 183 | Delayed CNS myelination (HP:0002188) | 1.53178351 |
| 184 | Hyperphosphatemia (HP:0002905) | 1.52856651 |
| 185 | Abnormal pancreas size (HP:0012094) | 1.51122225 |
| 186 | Widely patent fontanelles and sutures (HP:0004492) | 1.49629769 |
| 187 | Large eyes (HP:0001090) | 1.49214298 |
| 188 | Mitochondrial inheritance (HP:0001427) | 1.48369304 |
| 189 | Hyperglycinemia (HP:0002154) | 1.48359146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 8.23298917 |
| 2 | WNK4 | 6.26836739 |
| 3 | OXSR1 | 5.74057055 |
| 4 | ADRBK2 | 3.88607850 |
| 5 | GRK1 | 3.51928790 |
| 6 | BMPR1B | 3.17188134 |
| 7 | LATS1 | 2.93754487 |
| 8 | ACVR1B | 2.73741382 |
| 9 | STK39 | 2.66608244 |
| 10 | ZAK | 2.60935000 |
| 11 | TAOK3 | 2.54412102 |
| 12 | NTRK3 | 2.38561739 |
| 13 | PDK4 | 2.37781433 |
| 14 | PDK3 | 2.37781433 |
| 15 | NUAK1 | 2.19677781 |
| 16 | INSRR | 2.14429745 |
| 17 | MAP4K2 | 2.07445030 |
| 18 | MAP3K4 | 2.00598886 |
| 19 | SGK494 | 1.82968146 |
| 20 | SGK223 | 1.82968146 |
| 21 | WNK1 | 1.81669578 |
| 22 | TXK | 1.77931117 |
| 23 | MAPK13 | 1.74960878 |
| 24 | EPHA4 | 1.65088377 |
| 25 | BCKDK | 1.53461230 |
| 26 | NTRK1 | 1.52917021 |
| 27 | TNIK | 1.52317199 |
| 28 | STK38 | 1.43004964 |
| 29 | PDK2 | 1.42200179 |
| 30 | STK38L | 1.39940368 |
| 31 | MAP3K9 | 1.39811673 |
| 32 | SGK2 | 1.39633307 |
| 33 | MAP2K7 | 1.29417308 |
| 34 | TLK1 | 1.27801990 |
| 35 | MINK1 | 1.25844771 |
| 36 | CASK | 1.24841689 |
| 37 | TAF1 | 1.22582584 |
| 38 | MAPK15 | 1.21306420 |
| 39 | NLK | 1.19410973 |
| 40 | EPHA3 | 1.17685979 |
| 41 | MAP3K12 | 1.15665233 |
| 42 | MAP2K4 | 1.15494864 |
| 43 | PNCK | 1.12130556 |
| 44 | PRKD3 | 1.11843636 |
| 45 | RIPK4 | 1.11636716 |
| 46 | STK3 | 1.09766110 |
| 47 | PAK3 | 1.09722342 |
| 48 | MAP3K2 | 1.08435153 |
| 49 | SGK3 | 1.06508047 |
| 50 | MYLK | 1.05005672 |
| 51 | DAPK2 | 1.03935201 |
| 52 | TEC | 1.03578568 |
| 53 | VRK1 | 0.97278260 |
| 54 | MUSK | 0.96564946 |
| 55 | CAMKK2 | 0.96229388 |
| 56 | PTK2B | 0.93716565 |
| 57 | CSNK1A1L | 0.90981236 |
| 58 | BRSK2 | 0.89183126 |
| 59 | KSR2 | 0.85432906 |
| 60 | GRK6 | 0.81066486 |
| 61 | SGK1 | 0.79199412 |
| 62 | NEK1 | 0.78320983 |
| 63 | GRK5 | 0.78122871 |
| 64 | CSNK1G1 | 0.77993783 |
| 65 | DYRK2 | 0.76123572 |
| 66 | MARK1 | 0.75989437 |
| 67 | MAPKAPK3 | 0.75580347 |
| 68 | IKBKB | 0.71604048 |
| 69 | PIK3CG | 0.70241805 |
| 70 | PINK1 | 0.68632981 |
| 71 | CDC42BPA | 0.68199112 |
| 72 | PAK6 | 0.68176427 |
| 73 | FER | 0.68069479 |
| 74 | CSNK1G3 | 0.67459720 |
| 75 | CDK5 | 0.66109547 |
| 76 | DAPK1 | 0.65980495 |
| 77 | EIF2AK3 | 0.65903907 |
| 78 | PLK2 | 0.64832394 |
| 79 | ERBB2 | 0.63224927 |
| 80 | TRIM28 | 0.62083283 |
| 81 | ARAF | 0.61918150 |
| 82 | NTRK2 | 0.61743120 |
| 83 | PRKCH | 0.61595194 |
| 84 | PRKCG | 0.58852807 |
| 85 | CSNK1G2 | 0.58745859 |
| 86 | MAPKAPK5 | 0.58290132 |
| 87 | SYK | 0.57813673 |
| 88 | FRK | 0.56518129 |
| 89 | PRKAA1 | 0.56432373 |
| 90 | LMTK2 | 0.54801540 |
| 91 | CAMK2A | 0.54127057 |
| 92 | KSR1 | 0.54018044 |
| 93 | TGFBR1 | 0.53719964 |
| 94 | CAMK2B | 0.53167554 |
| 95 | PKN1 | 0.49926993 |
| 96 | CAMKK1 | 0.49732481 |
| 97 | BMPR2 | 0.49307225 |
| 98 | PRKAA2 | 0.47724907 |
| 99 | ITK | 0.47565404 |
| 100 | CDK8 | 0.45754322 |
| 101 | PTK2 | 0.44934484 |
| 102 | UHMK1 | 0.44783371 |
| 103 | PRKCQ | 0.44285992 |
| 104 | PDPK1 | 0.44098463 |
| 105 | SCYL2 | 0.43938778 |
| 106 | TIE1 | 0.43217828 |
| 107 | RPS6KA5 | 0.42830008 |
| 108 | CAMK1G | 0.42688515 |
| 109 | FLT3 | 0.42080979 |
| 110 | PRKCE | 0.41514741 |
| 111 | PIK3CA | 0.41272643 |
| 112 | MAP2K6 | 0.41182544 |
| 113 | PRKCI | 0.40799471 |
| 114 | PRKD1 | 0.40122784 |
| 115 | GRK7 | 0.39193171 |
| 116 | RET | 0.38956512 |
| 117 | LATS2 | 0.38862222 |
| 118 | NME1 | 0.38425764 |
| 119 | CSNK1D | 0.38191492 |
| 120 | BTK | 0.37949746 |
| 121 | MAP3K1 | 0.37816962 |
| 122 | PDK1 | 0.36975353 |
| 123 | MAP2K1 | 0.36525179 |
| 124 | PHKG2 | 0.36299317 |
| 125 | PHKG1 | 0.36299317 |
| 126 | PRKACA | 0.36188861 |
| 127 | CAMK2D | 0.36180054 |
| 128 | MELK | 0.35348762 |
| 129 | MAP2K2 | 0.35193062 |
| 130 | VRK2 | 0.34559845 |
| 131 | OBSCN | 0.34146399 |
| 132 | IRAK1 | 0.34006104 |
| 133 | IGF1R | 0.33583017 |
| 134 | TNK2 | 0.33406160 |
| 135 | AKT3 | 0.33147629 |
| 136 | STK11 | 0.32240002 |
| 137 | ABL1 | 0.32008182 |
| 138 | CDK9 | 0.31579274 |
| 139 | PLK3 | 0.31538057 |
| 140 | BLK | 0.31410978 |
| 141 | NEK9 | 0.31272386 |
| 142 | MKNK2 | 0.30553427 |
| 143 | SIK3 | 0.27850759 |
| 144 | CAMK2G | 0.26864333 |
| 145 | PRKACG | 0.26728894 |
| 146 | CDK19 | 0.26492823 |
| 147 | PRKCA | 0.24553557 |
| 148 | SIK2 | 0.23591927 |
| 149 | CSNK1A1 | 0.23523490 |
| 150 | RPS6KA3 | 0.23266490 |
| 151 | MAP3K7 | 0.23084271 |
| 152 | PRKCZ | 0.22798307 |
| 153 | MARK2 | 0.21103151 |
| 154 | ADRBK1 | 0.20730954 |
| 155 | CAMK1 | 0.20687320 |
| 156 | MST4 | 0.20119322 |
| 157 | MST1R | 0.20113897 |
| 158 | CDK14 | 0.17095121 |
| 159 | PRKD2 | 0.16353513 |
| 160 | BCR | 0.15812043 |
| 161 | HIPK2 | 0.15321396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.57826934 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.12638300 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.09001002 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.05852781 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.92163752 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.69629065 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.48826390 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.44409035 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.43160182 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.32640952 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.28759143 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.26424136 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.23472741 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.18562316 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.11176566 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.94457202 |
| 17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.93552121 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.92723978 |
| 19 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.87761097 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.85969607 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.85223498 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.76666037 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.76255784 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.75383909 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69303000 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.66535807 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.66391703 |
| 28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.65659170 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.65253447 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.62725169 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.61964648 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.59568666 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.55741056 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.50085428 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46234475 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.41886779 |
| 37 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.39911177 |
| 38 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.38879461 |
| 39 | Long-term potentiation_Homo sapiens_hsa04720 | 1.36971984 |
| 40 | GABAergic synapse_Homo sapiens_hsa04727 | 1.36568327 |
| 41 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.36139186 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32861759 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.32334938 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29684206 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.27622261 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.27300954 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 1.25966452 |
| 48 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.24243340 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.19890752 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19733181 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19087535 |
| 52 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18722627 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 1.17678108 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.17640210 |
| 55 | Salivary secretion_Homo sapiens_hsa04970 | 1.16642008 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14517441 |
| 57 | Huntingtons disease_Homo sapiens_hsa05016 | 1.10339232 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10007979 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.08839810 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.08708675 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 1.08199163 |
| 62 | Morphine addiction_Homo sapiens_hsa05032 | 1.08040139 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06775656 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05928444 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02867299 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 1.01931873 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01794280 |
| 68 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.00758713 |
| 69 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.97910764 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.96959845 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95488039 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95278913 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.92605015 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91848128 |
| 75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91847939 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90015408 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89596349 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.88891164 |
| 79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88303690 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86291213 |
| 81 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.86290357 |
| 82 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85479442 |
| 83 | Melanoma_Homo sapiens_hsa05218 | 0.85448807 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84689574 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83019441 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.80517729 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80353858 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80187545 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80175737 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79878959 |
| 91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77862746 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76429311 |
| 93 | Alcoholism_Homo sapiens_hsa05034 | 0.75486812 |
| 94 | Asthma_Homo sapiens_hsa05310 | 0.74677126 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74511406 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73254534 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73176704 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70700673 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69758461 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68970994 |
| 101 | RNA polymerase_Homo sapiens_hsa03020 | 0.68568923 |
| 102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68559905 |
| 103 | Protein export_Homo sapiens_hsa03060 | 0.68315055 |
| 104 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66933455 |
| 105 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.66001626 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64106487 |
| 107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63970285 |
| 108 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.62860597 |
| 109 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62200815 |
| 110 | Long-term depression_Homo sapiens_hsa04730 | 0.61886215 |
| 111 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57850557 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56728649 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56633555 |
| 114 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56410100 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55734988 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54301651 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.54088422 |
| 118 | RNA degradation_Homo sapiens_hsa03018 | 0.53832128 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53731698 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.52273902 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51975258 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51574297 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50593596 |
| 124 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50200814 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48413112 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46681738 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46552889 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44392775 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43807314 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43166009 |
| 131 | Gap junction_Homo sapiens_hsa04540 | 0.42982491 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.42818799 |
| 133 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41936778 |
| 134 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41768341 |
| 135 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41147225 |
| 136 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40677738 |
| 137 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40591314 |
| 138 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40454299 |
| 139 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39549164 |
| 140 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.38266733 |
| 141 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37917355 |
| 142 | Lysine degradation_Homo sapiens_hsa00310 | 0.36949875 |
| 143 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36721773 |
| 144 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35875021 |
| 145 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35857171 |
| 146 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35716046 |
| 147 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.35177490 |
| 148 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.34388714 |
| 149 | Purine metabolism_Homo sapiens_hsa00230 | 0.34151352 |
| 150 | Histidine metabolism_Homo sapiens_hsa00340 | 0.33074084 |
| 151 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32756601 |
| 152 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32505842 |
| 153 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.32152364 |

